The yeast meiotic activator IME1 stimulates transcription of many early meiotic genes. These genes share a 5 sequence called URS1. URS1 sites function as repression sites in cells that lack IME1; we show here that URS1 sites are weak activation sequences in cells that express IME1. Repression through URS1 sites is known to depend upon the URS1-binding protein UME6. We have identified a UME6 allele (previously called rim16-12) that causes a defect in IME1-dependent activation of meiotic genes but not in repression through URS1 sites. In contrast, a ume6 null mutation causes defects in both IME1-dependent activation and in repression through URS1 sites. A LexA-UME6 fusion protein is an IME1-dependent transcriptional activator, whereas a LexA-UME6 fusion carrying the rim16-12 substitution cannot activate transcription. These findings argue that IME1 activates meiotic genes by converting UME6 from a negative regulator to a positive regulator; the rim16-12 mutant protein is defective in conversion to a positive regulator.The yeast UME6 protein and URS1 site are components of a sequence-specific repression system. URS1 sites are widely distributed in genetic regulatory regions (29), where they function as repression sites in growing, nonmeiotic cells (4,10,12,17,31). Repression of URS1-containing genes requires the UME6 gene product (16,27). UME6 is a zinc cluster protein that binds specifically to a URS1 site in vitro (27). A second protein, the RPA1/2/3 heterotrimer (RP-A), also binds to URS1 sites (11). Binding of RP-A is independent of UME6 (16), and binding of recombinant UME6 is independent of RP-A (27). The functional relationship among RP-A, URS1, and other URS1-binding proteins is presently unclear. However, genetic analysis indicates that UME6 is a repressor or part of a repression complex that acts through URS1 sites in nonmeiotic cells (16,27).Three observations made in nonmeiotic cells indicate that the URS1/UME6 system participates in repression of early meiotic genes. First, URS1-like sites are found upstream of almost all early meiotic genes (4; see reference 14 for a compilation). Second, mutations that remove or disrupt these URS1 sites cause increased expression in nonmeiotic cells (1,4,31). Third, ume6 loss-of-function mutations cause increased early meiotic gene expression in nonmeiotic cells (1,26,27). Thus, repression by the URS1/UME6 system prevents inappropriate meiotic gene expression in nonmeiotic cells.Entry into meiosis is accompanied by elevated expression of IME1 (7); the IME1 gene product is required for expression of almost all meiotic genes (see reference 14 for a review). Two observations indicate that the URS1/UME6 system may be required for IME1 to activate early meiotic genes. First, mutations in the URS1 sites near the meiotic genes SPO13, HOP1, and IME2 cause reduced expression during meiosis (1,4,31). At HOP1 and IME2, mutations in nearby positive sites (called the UAS H [UAS, upstream activating sequence] and T 4 C sites) also cause reduced expression during meiosis (1, 31). S...